PL3423111T3 - Związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy związku do wykrywania nowotworów - Google Patents

Związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy związku do wykrywania nowotworów

Info

Publication number
PL3423111T3
PL3423111T3 PL17727737.3T PL17727737T PL3423111T3 PL 3423111 T3 PL3423111 T3 PL 3423111T3 PL 17727737 T PL17727737 T PL 17727737T PL 3423111 T3 PL3423111 T3 PL 3423111T3
Authority
PL
Poland
Prior art keywords
compound
cancer
detection
hydrolysis
kit
Prior art date
Application number
PL17727737.3T
Other languages
English (en)
Inventor
Adam LESNER
Magdalena WYSOCKA
Dawid NIDZWORSKI
Original Assignee
Instytut Biotechnologii I Medycyny Molekularnej
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biotechnologii I Medycyny Molekularnej filed Critical Instytut Biotechnologii I Medycyny Molekularnej
Publication of PL3423111T3 publication Critical patent/PL3423111T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0056—Peptides, proteins, polyamino acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/976—Trypsin; Chymotrypsin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PL17727737.3T 2016-03-04 2017-03-03 Związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy związku do wykrywania nowotworów PL3423111T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL416395A PL231469B1 (pl) 2016-03-04 2016-03-04 Nowy związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający nowy związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy nowego związku do wykrywania nowotworów
PCT/PL2017/000018 WO2017150997A1 (en) 2016-03-04 2017-03-03 Compound, process for its preparation, a pharmaceutical solution containing the compound, a method of determining the presence of cancer, a kit for cancer detection, and the use of hydrolysis of the compound for the detection of cancer

Publications (1)

Publication Number Publication Date
PL3423111T3 true PL3423111T3 (pl) 2024-09-02

Family

ID=58995198

Family Applications (2)

Application Number Title Priority Date Filing Date
PL416395A PL231469B1 (pl) 2016-03-04 2016-03-04 Nowy związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający nowy związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy nowego związku do wykrywania nowotworów
PL17727737.3T PL3423111T3 (pl) 2016-03-04 2017-03-03 Związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy związku do wykrywania nowotworów

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL416395A PL231469B1 (pl) 2016-03-04 2016-03-04 Nowy związek, sposób jego otrzymywania, roztwór farmaceutyczny zawierający nowy związek, sposób określania obecności choroby nowotworowej, zestaw do wykrywania nowotworów oraz zastosowanie hydrolizy nowego związku do wykrywania nowotworów

Country Status (4)

Country Link
US (1) US10556925B2 (pl)
EP (1) EP3423111B1 (pl)
PL (2) PL231469B1 (pl)
WO (1) WO2017150997A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL238871B1 (pl) * 2018-02-13 2021-10-18 Univ Gdanski Peptydomimetyk oraz jego zastosowanie jako środek fluorescencyjny in vitro

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL224854B1 (pl) 2013-08-23 2017-02-28 Univ Warszawski Nowy peptydomimetyk o aktywności antyangiogennej i zawierająca go kompozycja farmaceutyczna

Also Published As

Publication number Publication date
US10556925B2 (en) 2020-02-11
PL231469B1 (pl) 2019-02-28
US20190248835A1 (en) 2019-08-15
PL416395A1 (pl) 2017-09-11
EP3423111B1 (en) 2023-08-16
WO2017150997A1 (en) 2017-09-08
EP3423111A1 (en) 2019-01-09

Similar Documents

Publication Publication Date Title
EP3443119B8 (en) Methods for lung cancer detection
PL3425055T3 (pl) Odczynnik do molekularnego wykrywania/diagnostyki nowotworu
EP3286311A4 (en) Method for the treatment of malignancies
EP3156498A4 (en) Breast cancer detection kit or device, and method for detecting breast cancer
EP3159416A4 (en) Kit or device for detecting lung cancer, and lung cancer detection method
EP3221690A4 (en) System and method for detecting the authenticity of products
EP3370603A4 (en) SYSTEM AND METHOD FOR DETECTING BLOOD UNDER THE SURFACE
EP3242947A4 (en) Method for the treatment of malignancies
IL254687A0 (en) A bio-sensor system for rapid identification of an analyte
EP3183578B8 (en) Methods for the early detection of colorectal cancer
EP3280408A4 (en) Process for the preparation of dicycloplatin
EP3115467A4 (en) Method for assisting detection of pancreatic cancer
GB2533072B (en) Method for the processing of an aqueous hemicellulosic stream
GB201602210D0 (en) Detection of cancer
EP3250904A4 (en) Multi-threaded fluid parameter signal processing
AU2016248025B2 (en) Polymorphs of AFATINIB and its salts and process for the preparation of quinazolinyl derivatives
PL3380983T3 (pl) Sposób identyfikacji procesora bezpieczeństwa
GB201617628D0 (en) Method of determining presence of Isotopes
EP3233814A4 (en) Novel process for the preparation of ranolazine
EP3252469A4 (en) Method for simultaneous detection of blood cells having interacting molecules
GB201517279D0 (en) Method and system for improving the evaluation of an interaction between an analyte and a ligand using a biosensor
EP3637106A4 (en) LUNG CANCER DETECTION PROCEDURE
EP3540630A4 (en) METHOD OF DETECTING GLITTER
GB2564185B (en) Process for the preparation of derivatives of benzodioxole
EP3108256A4 (en) Method of detecting cancer